Phase 2 Chronic Subdural Hematoma Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2Phase 3
Prospective Clinical Investigation on Infection as a Cause of Chronic Subdural Hematoma.
Chronic Subdural Hematomas
University of Rostock164 enrolled1 locationNCT07556991
Recruiting
Phase 2Phase 3
Adjuvant Tranexamic Acid (TXA) Versus Surgery Alone for Adult Patients With Chronic Subdural Hematoma (CSDH)
Chronic Subdural Hematoma
St. Olavs Hospital274 enrolled1 locationNCT07245264
Recruiting
Phase 1Phase 2
Chronic Subdural Hematoma Treatment With Intra-Arterial Bevacizumab Injection
Chronic Subdural Hematoma
The Cooper Health System140 enrolled1 locationNCT06510582